Firering Strategic Minerals: From explorer to producer. Watch the video here.
This was posted by Paulie yesterday night if you cared to have scrolled down before asking for the link... Re Re RosesSat 20:27
As I said just for you listen 6.50 minutes in
Now we know there just waiting for results anytime now yeah
https://youtu.be/Qd-uOZCFfAs
Harman & Co’s respected veteran life sciences analyst, Dr Martin Hall, said recently: “ValiRx appears to be under-appreciated by the market. Reasons for this include the lack of institutional shareholders and a continuing need for more capital to advance its clinical programmes, thereby building value.
“On the back of clinical progress, the company is attracting potential commercial partners to help pay for the costs of late-stage development. This should be the catalyst needed to attract institutional investors into the company.”
Initial testing of the well has indicated that well C-37, if placed on full production, can produce up to 100 barrels of oil per day with a water cut of approximately 50 percent. Zenith will establish and communicate a stabilised flow rate to the market in due course.
Zenith is the only junior independent operator in the nation, where it owns an 80pc interest in three fields called Muradkhanli, Jafarli, and Zardab. The properties contain many active production wells and wells capable of production, alongside plenty of upside potential. All-in-all, the fields hold independently assessed 2P reserves of 31.7MMboe, which translates into an NPV (10) of $ 469m thanks to low all-in average production costs of $ 19 / bbl
The Company can confirm that continued flow testing of the well recorded a production rate of approximately 285 barrels of oil per day, adding significant uplift to Zenith's total in country production figure.
Yearly revenue of approximately US$5,500,000 is expected to be generated from C-37, and a stabilised flow rate of 285 represents a 114% increase in the Company's daily oil production.
Further stimulation of the